Why has corporate FCPA enforcement stopped?
Richard L. Cassin
May 3, 2021
The first four months of 2021 saw only one FCPA enforcement action against a corporate defendant. That’s the slowest start for at least 10 years.… Continue Reading
Editors
Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Shruti J. Shah
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
At Large: Are agents ever ‘legal’ under the FCPA?
Richard L. Cassin
August 6, 2020
My serious purpose in asking if agents are legal under the FCPA is about compliance with the accounting standards.… Continue Reading
At Large: Will Covid-19 ‘crony charities’ trigger the next wave of FCPA fumbles?
Richard L. Cassin
May 7, 2020
The first reports appeared Saturday. They said businesses and individuals in some countries are under pressure to donate to Covid-19 relief charities that have close ties to government officials.… Continue Reading
Management can own honesty or deceit. So pick one
Richard Bistrong
April 17, 2019
At Fresenius Medical Care, according to a recent post on the FCPA Blog, management owned the graft and senior executives directed the bribery and the global cover up. The failures were both wide and deep, where “legal, compliance, and internal audit functions failed to detect and prevent the bribery,” the company said in an SEC filing.… Continue Reading
At Fresenius, management owned the graft
Richard L. Cassin
April 4, 2019
The SEC summed up the criminal activity in the corner offices this way: In many instances, senior management actively thwarted compliance efforts, personally engaging in corruption schemes and directing employees to destroy records of the misconduct.… Continue Reading
Fresenius Medical pays $231 million to settle widespread FCPA offenses
Richard L. Cassin
March 29, 2019
The world’s biggest provider of dialysis equipment and services agreed Friday to pay the DOJ and SEC $231 million in penalties and disgorgement to resolve violations of the Foreign Corrupt Practices Act across Africa, the Middle East, and Europe.… Continue Reading
Dialysis provider reserves $245 million for FCPA settlement
Richard L. Cassin
February 27, 2018
Fresenius Medical Care AG said in a securities filing Tuesday that it has set aside €200 million ($245 million) for a potential FCPA resolution with the DOJ and SEC.
Fresenius, based in Homburg, Germany, said the money “represents an estimate from a range of potential outcomes.”… Continue Reading